Evidence map›Paper›PMID 35570274›Full record

ArticleMalaria journal2022

Exo-erythrocytic development of Plasmodium matutinum (lineage pLINN1) in a naturally infected roadkill fieldfare Turdus pilaris.

Helene Pendl, Carolina Hernández-Lara, Jakub Kubacki, Nicole Borel, Sarah Albini, Gediminas Valkiūnas

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Unraveling the host range ofParasitology · 2025
    Article
  4. Review
  5. Article
  6. Unexpected absence of exo-erythrocytic merogony during high gametocytaemia in two species ofInternational journal for parasitology. Parasites and wildlife · 2024
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Helene PendlPendl Lab, Untere Roostmatt 7, 6300, Zug, Switzerland.
Carolina Hernández-LaraNature Research Centre, Akademijos 2, 08412, Vilnius, Lithuania.
Jakub KubackiInstitute of Virology, Vetsuisse Faculty, University of Zürich, Winterthurerstrasse 266a, 8057, Zurich, Switzerland.
Nicole BorelInstitute of Veterinary Pathology, Vetsuisse Faculty, University of Zürich, Winterthurer Strasse 268, 8057, Zurich, Switzerland.
Sarah AlbiniSection of Poultry and Rabbit Diseases, Institute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zürich, Winterthurerstrasse 270, 8057, Zurich, Switzerland.
Gediminas ValkiūnasNature Research Centre, Akademijos 2, 08412, Vilnius, Lithuania. gediminas.valkiunas@gamtc.lt.
University of Zurich · CHNature Research Centre · LT

Funding

Lietuvos Mokslo Taryba 09.3.3-LMT-K-712-19-0005
6 · The paper itself

Abstract

backgroundSpecies of Plasmodium (Haemosporida, Plasmodiidae) are remarkably diverse haemoparasites. Information on genetic diversity of avian malaria pathogens has been accumulating rapidly, however exo-erythrocytic development of these organisms remains insufficiently addressed. This is unfortunate because, contrary to Plasmodium species parasitizing mammals, the avian malaria parasites undergo several cycles of exo-erythrocytic development, often resulting in damage of various organs. Insufficient knowledge on the exo-erythrocytic development in most described Plasmodium species precludes the understanding of mechanisms of virulence during avian malaria. This study extends information on the exo-erythrocytic development of bird malaria parasites.

methodsA roadkill fieldfare (Turdus pilaris) was sampled in Switzerland and examined using pathologic, cytologic, histologic, molecular and microbiologic methods. Avian malaria was diagnosed, and erythrocytic and exo-erythrocytic stages of the parasite were identified using morphologic characteristics and barcode DNA sequences of the cytochrome b gene. The species-specific characteristics were described, illustrated, and pathologic changes were reported.

resultsAn infection with Plasmodium matutinum lineage pLINN1 was detected. Parasitaemia was relatively low (0.3%), with all erythrocytic stages (trophozoites, meronts and gametocytes) present in blood films. Most growing erythrocytic meronts were markedly vacuolated, which is a species-specific feature of this parasite's development. Phanerozoites at different stages of maturation were seen in leukocytes, macrophages, and capillary endothelial cells in most organs examined; they were particularly numerous in the brain. Like the erythrocytic meronts, growing phanerozoites were markedly vacuolated. Conspicuous exo-erythrocytic development and maturation in leucocytes suggests that this fieldfare was not adapted to the infection and the parasite was capable to escape from cellular immunity.

conclusionsThis is the first report of exo-erythrocytic development of the malaria parasite lineage pLINN1 during single infection and the first report of this lineage in the fieldfare. The findings of multiple phanerozoites in brain, skeletal muscle, and eye tissue in combination with signs of vascular blockage and thrombus formation strongly suggest an impaired vision and neuromuscular responsiveness as cause of the unexpected collision with a slowly moving car. Further studies on exo-erythrocytic stages of haemosporidian parasites are pivotal to understand the true level of populational damage of avian malaria in wild birds.

Indexed as

HaemosporidaMalaria, AvianPlasmodiumSongbirdsAnimalsEndothelial CellsMammalsPhylogenyBirdsExo-erythrocytic developmentPlasmodium matutinumpLINN1RoadkillVirulence

Identifiers

PMID35570274
PMCPMC9107739
OpenAlexW4280508631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.